Boston Scientific (BSX)
42.43
+0.00 (0.00%)
NYSE · Last Trade: Oct 29th, 7:40 AM EDT
News & Press Releases
Boston Scientific Q3 Earnings Call Highlightsmarketbeat.com
Boston Scientific (NYSE:BSX) reported third-quarter 2026 results that fell below its prior guidance after a cybersecurity incident disrupted manufacturing and product shipments for eight business days, while competitive and pricing pressures weighed on key cardiovascular franchises.
Organic revenue
Via MarketBeat · October 29, 2026
Boston Scientific: 3 Key Takeaways for Long-Term Investorsfool.com
Cost cuts and pipeline launches aim to restore growth momentum after 2027 headwinds flatten earnings.
Via The Motley Fool · October 29, 2026
Stock Market Today, Oct. 28: Boston Scientific Slips 6% After Cutting Q4 Sales and Full-Year EPS Guidance on Cyberattack Impactfool.com
Today, Oct. 28, 2026, the medical device maker slashed profit expectations after an August cyberattack continued disrupting operations.
Via The Motley Fool · October 28, 2026
Boston Scientific (NYSE:BSX) Q3 2026 Results In Line, Stock Slips Premarketchartmill.com
Via Chartmill · October 28, 2026
S&P 500 Top Movers: Gainers and Losers in Today's US Sessionchartmill.com
Via Chartmill · October 28, 2026
S&P 500 Most Active Stocks for October 28, 2026chartmill.com
Via Chartmill · October 28, 2026
Boston Scientific (BSX) Q3 2026 Earnings Call Transcriptfool.com
Cybersecurity disruption and competitive pressures weighed on third-quarter results.
Via The Motley Fool · October 28, 2026
Why Boston Scientific (BSX) shares are plunging today
What happened? Shares of medical device company Boston Scientific (NYSE:BSX) fell 8% in the morning session after the company reported third-quarter 2026 fin...
Via StockStory · October 28, 2026
S&P 500 Gap Movers: Oct. 28 Sessionchartmill.com
Via Chartmill · October 28, 2026
S&P 500 Premarket Movers for Oct. 28, 2026chartmill.com
Via Chartmill · October 28, 2026
Boston Scientific (NYSE:BSX) posts better-than-expected sales in Q3 2026 but quarterly revenue guidance misses expectations
Medical device company Boston Scientific (NYSE:BSX) announced better-than-expected revenue in Q3 2026, with revenue rising 1.4% year on year to $5.14 billion...
Via StockStory · October 28, 2026
Earnings to watch: Boston Scientific (BSX) reports Q3 results tomorrow
Medical device company Boston Scientific (NYSE:BSX) will be reporting results this Wednesday before market open. Here’s what to look for. Boston Scientific b...
Via StockStory · October 26, 2026
BOSTON SCIENTIFIC CORPORATION INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Boston Scientific Corporation’s Directors and Officers for Breach of Fiduciary Duties – BSX
Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Boston Scientific Corporation (NYSE: BSX) failed to manage Boston Scientific in an acceptable manner, breaching their fiduciary duties to Boston Scientific, and whether Boston Scientific and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know:
By Scott+Scott Attorneys at Law LLP · Via Business Wire · October 22, 2026
1 Stock Under $50 with Exciting Potential and 2 We Question
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However...
Via StockStory · October 21, 2026
1 Safe-and-Steady Stock to Research Further and 2 Facing Challenges
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. Fi...
Via StockStory · October 8, 2026
2 Cash-Producing Stocks Worth Investigating and 1 That Underwhelm
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...
Via StockStory · October 5, 2026
2 Oversold Stocks Primed to Rebound and 1 We Find Risky
The past year hasn’t been kind to the stocks featured in this article. Each has tumbled to its lowest point in 12 months, leaving investors to decide whether...
Via StockStory · October 2, 2026
2 Profitable Stocks to Research Further and 1 We Avoid
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ...
Via StockStory · October 1, 2026
2 Value Stocks with Exciting Potential and 1 We Avoid
Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built the...
Via StockStory · September 22, 2026
Unpacking Q2 Earnings: Boston Scientific (NYSE:BSX) In The Context Of Other Medical Devices & Supplies - Diversified Stocks
Looking back on medical devices & supplies - diversified stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Boston Scientifi...
Via StockStory · September 13, 2026
1 of Wall Street’s Favorite Stocks with Promising Prospects and 2 Facing Challenges
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic...
Via StockStory · September 10, 2026
2 Healthcare Stocks with Competitive Advantages and 1 We Question
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only reali...
Via StockStory · September 9, 2026
Uncover the latest developments among S&P500 stocks in today's session.chartmill.com
Via Chartmill · September 8, 2026
These S&P500 stocks are moving in today's pre-market sessionchartmill.com
Via Chartmill · September 8, 2026
Thursday's session: top gainers and losers in the S&P500 indexchartmill.com
Via Chartmill · September 3, 2026